F2, CPTAC-3432 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Protein Sequence hover to view complete sequence

non-CPTAC-3432: View additional YGFYTHVFR data

10 20 30 40 50
MSHVRGLGLP GCLALAALVS LVHSQHVFLA PQQALSLLQR VRRANSGFLE
60 70 80 90 100
ELRKGNLERE CVEEQCSYEE AFEALESPQD TDVFWAKYTV CDSVRKPRET
110 120 130 140 150
FMDCLEGRCA MDLGVNYLGT VNVTHTGIQC QLWRSRYPHK PEINSTTHPG
160 170 180 190 200
ADLKENFCRN PDSSTTGPWC YTTDPTVRRE ECSVPVCGQE GRTTVVMTPR
210 220 230 240 250
SGGSKDNLSP PLGQCLTERG RLYQGNLAVT TLGSPCLPWN SLPAKTLSKY
260 270 280 290 300
QDFDPEVKLV ENFCRNPDWD EEGAWCYVAG QPGDFEYCNL NYCEEAVGEE
310 320 330 340 350
NYDVDESIAG RTTDAEFHTF FNEKTFGLGE ADCGLRPLFE KKSLKDTTEK
360 370 380 390 400
ELLDSYIDGR IVEGWDAEKG IAPWQVMLFR KSPQELLCGA SLISDRWVLT
410 420 430 440 450
AAHCILYPPW DKNFTENDLL VRIGKHSRTR YERNVEKISM LEKIYVHPRY
460 470 480 490 500
NWRENLDRDI ALLKLKKPVP FSDYIHPVCL PDKQTVTSLL RAGYKGRVTG
510 520 530 540 550
WGNLRETWTT NINEIQPSVL QVVNLPIVER PVCKASTRIR ITDNMFCAGF
560 570 580 590 600
KVNDTKRGDA CEGDSGGPFV MKSPFNNRWY QMGIVSWGEG CDRKGKYGFY
610 618
THVFRLKRWI QKVIDQFG

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for non-CPTAC-5620 Collapse assay details

Data source: Panorama

Official Gene Symbol

F2

Peptide Sequence

TTDAEFHTFFNEK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

312

Peptide End

324

CPTAC ID

non-CPTAC-5620

Peptide Molecular Mass

1,585.7049

Species

Mus musculus (Mouse)

Assay Type

Direct MRM

Matrix

Plasma

Submitting Laboratory

UVic-Genome BC Proteomics Centre

Submitting Lab PI

Christoph Borchers


Publication

View Details (opens in a new window)

Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

Agilent 6490/6495 QQQ

Internal Standard

synthetic peptide

Peptide Standard Purity

>80%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

1290 LC (Agilent)

Column Packing

Zorbax Eclipse Plus C18, 1.8 µm

Column Dimensions

2.1 x 150 mm

Flow Rate

400 µL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b9 (2+) | 12.6 | 9.7 | 17.1 | 16.5 | 8.6 | 23.4 | 20.8 | 13 | 29 | 15 | 15 | 15 | | b2 (1+) | 2.8 | 2.5 | 3.4 | 5.1 | 6.1 | 4.3 | 5.8 | 6.6 | 5.5 | 15 | 15 | 15 | | y11 (2+) | 3.2 | 2.9 | 3.4 | 5.3 | 8.5 | 3.9 | 6.2 | 9 | 5.2 | 15 | 15 | 15 | | y12 (2+) | 5.8 | 2.4 | 2.9 | 9.9 | 7.3 | 4.1 | 11.5 | 7.7 | 5 | 15 | 15 | 15 | | y6 (1+) | 6.4 | 3.8 | 3.1 | 8.6 | 7.4 | 4.2 | 10.7 | 8.3 | 5.2 | 15 | 15 | 15 | | sum | 2.2 | 1.5 | 1.8 | 4.4 | 6.5 | 3.2 | 4.9 | 6.7 | 3.7 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-3432 Collapse assay details

Data source: Panorama

Official Gene Symbol

F2

Peptide Sequence

YGFYTHVFR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

597

Peptide End

605

CPTAC ID

non-CPTAC-3432

Peptide Molecular Mass

1,188.5716

Species

Mus musculus (Mouse)

Assay Type

Direct MRM

Matrix

Plasma

Submitting Laboratory

UVic-Genome BC Proteomics Centre

Submitting Lab PI

Christoph Borchers


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

Agilent 6490/6495 QQQ

Internal Standard

synthetic peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

1290 LC (Agilent)

Column Packing

Zorbax Eclipse Plus C18, 1.8 µm

Column Dimensions

2.1 x 150 mm

Flow Rate

400 µL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y6 (2+) | 7.5 | 6.6 | 8.5 | 22.3 | 7.3 | 10.1 | 23.5 | 9.8 | 13.2 | 15 | 14 | 15 | | y7 (2+) | 4.2 | 9.5 | 6.2 | 14.8 | 11.8 | 7.1 | 15.4 | 15.1 | 9.4 | 15 | 14 | 15 | | y8 (2+) | 8.7 | 5.3 | 5.4 | 16.2 | 10.4 | 6.7 | 18.4 | 11.7 | 8.6 | 15 | 14 | 15 | | y4 (1+) | 8.2 | 7.4 | 7.5 | 10.8 | 10.5 | 6.9 | 13.6 | 12.8 | 10.2 | 15 | 14 | 15 | | y5 (1+) | 4.8 | 6.3 | 5.9 | 9.1 | 9 | 6.4 | 10.3 | 11 | 8.7 | 15 | 14 | 15 | | sum | 4.9 | 4.6 | 3.5 | 14.5 | 8.7 | 4.4 | 15.3 | 9.8 | 5.6 | 15 | 14 | 15 |



Additional Resources and Comments